LCS
CANO

Levin Capital Strategies’s Cano Health, Inc. CANO Stock Holding History

Levin Capital Strategies’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,650
Closed -$41.8K – 326
2023
Q3 		$41.8K Sell
1,650
-1,400
-46% -$115K 0.01% 258
2023
Q2 		$424K Buy
+3,050
New +$391K 0.05% 144
2023
Q1 		– Sell
-750
Closed -$103K – 289
2022
Q4 		$103K Buy
750
+500
+200% +$169K 0.01% 211
2022
Q3 		$217K Buy
250
+25
+11% +$15.7K 0.03% 178
2022
Q2 		$99K Buy
225
+5
+2% +$2.61K 0.01% 228
2022
Q1 		$140K Buy
+220
New +$139K 0.01% 269

Other funds holding CANO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Levin Capital Strategies's CANO Position: Q4 2023 in Review

Levin Capital Strategies sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 1,650 shares — an estimated $41.8K sold.

Levin Capital Strategies first reported a position in CANO in Q1 2022 and held it in 6 quarters. The position peaked at $424K in Q2 2023. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Levin Capital Strategies reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Levin Capital Strategies sold 1,650 Cano Health, Inc. shares in Q4 2023, an estimated $41.8K.
  • Levin Capital Strategies first reported a position in Cano Health, Inc. in Q1 2022 and held it in 6 quarters.
  • Levin Capital Strategies's Cano Health, Inc. position peaked at $424K in Q2 2023.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Levin Capital Strategies's 13F filing for Q4 2023, filed 6 Feb 2024.